Search:
You do not have permission to access this chart.
Please Sign Up or Login
News for Tricida, Inc. (TCDA)
minutes ago | Banggood.com
58 minutes ago | Aliexpress.com
2 weeks ago | GlobeNewsWire
2 months ago | Business Wire
2 months ago | GlobeNewsWire
3 months ago | GlobeNewsWire
3 months ago | GlobeNewsWire
3 months ago | GlobeNewsWire
3 months ago | Zacks Investment Research
4 months ago | GlobeNewsWire
4 months ago | GlobeNewsWire
4 months ago | GuruFocus
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Sector:
HealthcareIndustry:
BiotechnologyEmployees:
64Address:
Tricida, Inc. 7000 Shoreline Court Suite 201 South San Francisco CA 94080 United StatesWebsite:
Main page